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Israel 
1. Introduction 
During the last years of the 20th century, diagnosis in liver pathology was enriched by 
additional methodologies including immunohistopathology and confocal microscopy. 
Nevertheless, it soon became obvious that ultrastructural examinations remain essential 
in both research and diagnosis. The present chapter focuses on the use of electron 
microscopy in diagnostic hepatology and research of unsolved mechanisms. Attention 
will be directed to the correct retrieval of specimens for electron-microscopic examination 
and their processing for obtaining maximal information. The revival of interest in both 
transmission (TEM) and scanning electron microscopy (SEM) follows continuous changes 
in the subjects under examination: new diseases or additional features of old diseases; 
new therapeutic agents and their potentially hepatotoxic effects; environmental factors 
affecting the liver; identification of viruses and/or other rare noxious agents; immune 
pathology including liver transplantation and rejection; the liver in systemic-genetic 
diseases; and ultrastructural pathology in both experimental animals and cell cultures.   
We herewith wish to provide the clinician (neonatologist, pediatrician, geneticist, and 
hepatologist-gastroenterologist) with information about the value of electron-microscopic 
examination before performing a liver biopsy and thus enabling him/her to preserve a 
minute sample for a valuable study.  
In his limited size, the present chapter cannot be all-inclusive. Many areas, in which the 
contribution of electron-microscopy is limited to research investigations, have been left out. 
Similarly, areas in which histopathology and immune staining are major diagnostic tools, 
such as in hepatitis, were sidestepped. 
2. Technical aspects 
Whenever an electron microscopic examination is planned, immediate fixation of the 
retrieved specimen is essential. While most laboratories have their own preference,  
2.5% buffered glutaraldehyde is universally accepted.  Suggested primary fixative:  
2.5% glutaraldehyde in 0.1M sodium Cacodylate buffer (Add 1ml of 25% glutaraldehyde 
stock to 9 ml of buffer). The specimen should not be larger than 1 mm in each direction  
to allow for good penetration of the fixative. It is advised to avoid the tip of the cylindrical 
needle biopsy specimen which may contain sub-capsular liver area and may not  
be diagnostic. After 2 hrs. (At room temperature or in the refrigerator) continue with  
the standard steps: osmium post-fixation, dehydration, infiltration, embedding. Do not 
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freeze at any stage! (For immune-electron microscopy, keep a separate deep-frozen 
specimen.) 
Toluidine blue staining of thick (semi-thin 0.5 µm or 1.0 µm.) sections for TEM, used as guideline 
to the area of interest and further trimming: Reagents: 1% Toluidine Blue and 2% borate  
in distilled water. Ultrathin sections, 40-100 nm (regularly 60 nm for TEM) are spread mostly 
on 200 or 300 mesh copper grids and stained with uranyl acetate and lead citrate solutions. 
For iron-containing compounds, keep unstained sections or stained only 2 minutes with 
lead. 
Table I summarizes findings in biopsies of most conditions encountered in clinical cases. 
The reader can find details in the many books and atlases on hand (Johannessen, 1978; 
Tanikawa et al., 1979; Ghadially, 1997)). 
3. The liver biopsy – general features 
Hepatocytes: The large, round nuclei usually show an even, round contour and contain  
1-2 nucleoli, heterochromatin adjacent to their external border and distinct nuclear 
membranes and nuclear pores. Uneven, crenated nuclei can follow faulty fixation or other 
processing problems (Fig. 1). Chromatin margination and fragmentation can indicate 
apoptosis. In more advanced stages of damage, apoptotic and necrotic cells are seen  
(Figs. 2-6). 
3.1 Damaged and dying liver cells 
If the biopsy specimen has been retrieved and fixed correctly, it can be assumed that 
damaged liver cells indicate a pathological process. The sequences are: edema, swelling of 
mitochondria, cristolysis, flocculated matrix, nuclear chromatin clumping, margination and 
fragmentation, (apoptosis), RER denudation, dense deposits in mitochondria, peroxysomes 






Fig. 1. Delayed fixation: 
cristolysis and "extracted" 
matrix of mitochondria; 
fragmented euchromatin 
(arrow). x 8,000 
 
Fig. 2. Necrotic cells in 
periportal area.  Residual 
necrotic nucleus (arrow).      
x 5,000 
 
Fig. 3. Disintegrating cell in 
sinusoid: small nucleus, 
membraneous lysosomes 
and some collagen fibers 
(arrows).   x 6,000 
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Fig. 4. Apoptotic body: 
parts of nucleus (N), RER 
(arrow) and remaining 
mitochondria in the center.  
x 6,000 
Fig. 5. Extreme biliary 
necrosis. x 4,000 
Fig. 6. Biliary necrosis in a 
detached hepatocyte in the 
sinusoid.  x 5,000 
4. Organelle pathology (1): Mitochondria 
4.1 Shape and size 
Megamitochondria (giant mitochondria, up to 10.0 µm long), existing in numerous 
metabolic abnormalities including drug reactions and fatty liver; they are frequently 
elongated along their longitudinal axis. They may contain crystals (Figs. 7, 8), (Sternlieb, 
1979). Amoeboid shape, found in metabolic abnormalities and Reye syndrome (Partin et al., 
1971); Oncocytic transformation: mitochondrial crowding similar to an oncocytoma 
(Tandler et al., 1970) is found generally in hepatocytes in mitochondrial DNA deficiency 
(Mandel et al., 2001). 
 
 
Fig. 7. Fatty liver - NAFLD. 
Megamitochondrion with 
longitudinal crystal 
formations. x 15,000 
Fig. 8. Lactic acidosis. 
Angular mitochondrion 
with twisted and circular 
cristae. x 15,000 
Fig. 9. "Condensed 
conformation" of 
mitochondria in "edge 
artifact". x 8,000 
4.2 Content: matrix, cristae, crystals, granules, dense deposits 
Orthodox vs. Condensed mitochondria. Surrounding conditions induce mitochondrial 
changes. Mitochondria with dilated cristae and condensed (opaque) matrix are labeled in 
N 
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‘condensed’ conformation, whereas the apparently ‘normal’ mitochondria are termed to be in 
‘orthodox’ conformation (Hackenbrock et al., 1971).  Condensed mitochondria are seen at the 
periphery of a thin section, where all cellular components appear more diluted (Fig. 9). We 
have termed this finding as edge artifact. Condensed mitochondria may be seen in 
pathological conditions (e.g. Wilson disease) and thus have diagnostic significance. 
Therefore we suggest avoiding an edge artifact by assessing mitochondria also at safe 
distance away from the edge. 
Cristolysis is a significant, non-specific, sign of mitochondrial injury, when only fragments  
of cristae remain visible, severed from inner mitochondrial membranes (see Reye 
syndrome). 
Circular or ‘curled’ cristae are classically seen in cholestasis (Figs. 10, 11); (Phillips et al., 1987); 
occasionally the cristae are twisted (Figs. 8, 11, 12.).  Other variations in amount, position 
and arrangement remain unexplained, such as: longitudinally stacked; transverse position, 
perpendicular to the outer membrane; or cartwheel arrangement (Menkes’ kinky hair 
disease) (Ghadially, 1997). 
Autolytic changes: specimens retrieved post mortem show ‘extraction’ of matrix and cristae, 
resulting in empty-looking organelles and nuclei, similar to that of defectively fixed 
specimens (Fig. 1).  Dense deposits in mitochondria have been found in Wilson disease (Fig. 
13); (Phillips et al., 1987) and in severe iron overload (Bessis & Weed, 1973). 
Matrical dense granules, a common, normal feature of mitochondria, are known to contain 
calcium, but their precise role in mitochondrial function is unknown. However, their 
generalized absence is an indication of abnormality (drug toxicity, metabolic disturbance?). 
Large granules may show a hollow center (Fig. 11). 
 
Fig. 10. Circular and 
stacked cristae in 
cholestasis. Neonatal 
hepatitis.  x 10,000 
Fig. 11. Metabolic acidosis.   
Cristolysis and hollow 
granules (arrow), also in 
mitochondrion  x 15,000 
Fig. 12. Metabolic acidosis. 
Circular and twisted 
cristae in a mega-
mitochondrion. x 20,000 
Intramitochondrial inclusions: crystalline, paracrystalline, and filamentous. Crystalline 
inclusions, have been found in nuclei, cytoplasm  and mitochondria (Ghadially, 1997)  
and show a highly ordered pattern of organization. Crystals with a less ordered 
arrangement have been named crystalloid or paracrystalline.  The appearance of the crystals 
depends ’inter alia’ on the plane of sectioning in relationship to the plane of crystal lattice  
(Figs 7, 14, 15). 
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Fig. 13. Wilson disease. 
Elongated mitochondria 
and dense deposits.            
x 15,000. 
Fig. 14. Aspirin toxicity. 
Transverse section through 
paracrystalline formations.    
x 20,000. 
Fig. 15. Aspirin toxicity. 
Crystalline deposits in 
giant, abnormal 
mitochondrion. x 20,000 
4.3 Organelle pathology (2): Peroxisomes 
Peroxisomes (microbodies) are seen in hepatocytes as round, ellipsoid, slightly angular or 
elongated organelles. They contain a homogeneous, amorphous, finely granular or 
flocculent matrix, surrounded by a single tripartite membrane. Randomly distributed in the 
cytoplasm, they may form clusters. Their diameter is 0.25-1.34 µm and they may exhibit a 
peripheral terminal or marginal plate of about 0.4 µm long along their limit membrane (Fig. 
16).  They show variations in number, size, shape and matrix (Fig. 17). The major 
pathological finding is the absence of peroxisomes in the cerebrohepatorenal syndrome of 
Zellweger. Conditions with fewer peroxisomes (Table I) comprise Infantile Refsum disease 
(Fig. 18) whereas abundant organelles were reported in Reye syndrome, alcoholic liver 
disease, clofibrate and 6-mercaptopurine therapy and cholestatic jaundice of pregnancy 
(Sternlieb, 1979).  
 
 
Fig. 16. Siderosome (arrow) 
vs. peroxysomes (P), one 
with a terminal plate 
(arrowhead) x 15,000 
Fig. 17. Metabolic acidosis. 
Longitudinal arrangement 
of cristae and multiple 
large peroxysomes (P).       x 
15,000 
Fig. 18. Infantile Refsum 
disease, Zellweger variant, 
absent peroxisomes.  Note 
trilaminar filaments and 








 Liver Biopsy 
 
114 
4.4 Organelle pathology (3): Lysosomes 
These Golgi-derived organelles are of major importance in the interpretation of liver 
biopsies. Their role in autophagy (phagosomes; autophagosomes, autophagolysosomes) and 
apoptosis has been documented by numerous observations (Ghadially, 1997).  In practice, 
some lysosomes are indicative, if no diagnostic, of a group of conditions.  Within such a group, 
further differentiation requires additional (mainly genetic) information. For instance, among 
storage diseases, identifying a particular mucopolysaccharidosis can be difficult:  the 
lysosomes are similar, apparently empty, round or oval single-membrane bound vacuoles 
(Figs. 19-21.) and may contain a small electron-dense ‘nucleoid’.  Such appearances have 
been designated as “the bull’s eye” (Fig. 19). 
In some cases, the lysosome content discloses the origin of the partially degraded 
component secluded by autophagy: Glycogen storage disease type II (GSD II, acid maltase 
or lysosomal alpha–glucosidase deficiency) is typically diagnostic by the presence of 
modified glycogen molecules (Fig. 22),  (McAdams et al., 1974). Siderosomes contain ferritin  
and/or hemosiderin (Iancu, 1992) and aurosomes and platinosomes the respective metals 
(Ghadially, 1997);  lipolysosomes contain fat droplets (Hayashi & Sternlieb, 1975);  
Experiments with Thorotrast and carbon particles have demonstrated the phagocytic 
capacities of lysosomes (Ghadially, 1997). 
5. Inborn lysosomal and metabolic diseases 
5.1 Lysosomal diseases 
The established criteria for this group of conditions have been postulated by Hers (Hers, 
1963) as follows: “genetic deficiency of one of the acid hydrolases that is normally localized 
within the lysosome; consequent accumulation of undigested material within single-
membrane-bound organelles that are altered lysosomes”. The classical example of lysosomal 
storage disease, GSD II is due to lysosomal alpha-glucosidase deficiency, an enzyme 
encoded in humans by the GAA gene. 
Lysosomal storage disorders have been listed in numerous publications and recently by 
Pastores (Pastores, 2010). This classification, as well as the present Table I, is based on the 
relevant substrate involved. We have selected previously unpublished electron micrographs 
to exemplify diagnostic features. 
 
Fig. 19. "Bull's eye" 
appearance of nucleoid-
containing lysosomes in 
mucopolyscaccharidoses.  
(Hurler). x 15,000
Fig. 20.  Sinusoidal cell:  
Mucopolysaccharidosis 
(Hunter).  Note typical 
lysosomes. x 6,000 
Fig. 21. Mucopoly-
saccharidosis. "Empty 
looking" lysosomes and 
degraded phagolysosomes.  
(Morquio). x 6,000 
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bodies (arrows). x 10,000 
Fig. 23. GM1 Gangliosi-
dosis (Landing). Filaments 
in a large lysosome; dense 
deposits, possibly related to 
TPN.   x 10,000 
Fig. 24. Sialidosis: 
numerous single-
membrane limited 
lysosomes in a sinusoid.     
x 5,000 
5.1.1 Mucopolysaccharidoses (MPS) 
This group includes diseases with intralysosomal storage and urinary excretion of partially 
degraded mucopolysaccharides.  By TEM, single-membrane-bound bodies show scarce 
flocculent and particulate precipitate lying in a lucent matrix in many tissues (Tondeur and 
Neufeld, 1975).  They are found in various diseases of the group (see Table 1), with only 
minor differences (Figs. 19-21). Of interest is the presence of a “nucleoid”, remnant after 
extraction by processing of lysosomal content (Fig. 19). The appearance of several other 
conditions with empty-looking lysosomes and occasional electron-dense deposits may 
generate diagnostic difficulties, e.g. gangliosidosis (Fig. 23) sialidosis (Fig. 24), fucosidosis, 
mannosidosis. 
5.1.2 Gaucher disease (GD) 
The most prevalent lysosomal storage disease, GD is due to a deficiency of 
glucocerebrosidase leading to accumulation of glucosylceramide in “Gaucher cells”, in the 
liver and other organs. These cells can be found in other conditions (pseudo-Gaucher cells) 
but characteristically in the three forms of GD: Type I-chronic non-neuropathic, (90% in 
Ashkenazi Jews); Type II (acute neuropathic); and Type III (subacute neuropathic). Bone 
marrow or liver biopsy examinations for diagnosis have been replaced by 
glucocerebrosidase determination in leukocytes or cultured fibroblasts, or by mutation 
analysis. Liver biopsy is reserved for hydrops fetalis in congenital GD or unclear cases of 
hepatosplenomegaly. The pale-staining cytoplasm of the large, multinucleated Gaucher 
cells, show by TEM large lysosomes containing long tubules, some twisted and intermingled 
(Fig. 25). (Chakrapani & Green, 2004) 
5.1.3 Niemann–Pick Disease (NPD) including type A (NPA), B (NPB) and C (NPC) 
NPDs of various types can begin as fetal disease or neonatal jaundice. Some types and 
mutants can show relatively late-onset hepatosplenomegaly. The histopathological 
characteristic of this group of storage diseases is the presence of “foamy cells” storing 
sphyngomyelin. While diagnosis of NPA and NPB is by sphingomyelinase assays and 
mutation analysis, NPC1 need be diagnosed by mutational analysis at the level of cDNA 
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and/or assaying cultured fibroblasts for cholesterol esterification and staining for 
unesterified cholesterol with filipin (Meiner et al., 2001). The advantage of TEM over these 
methods is that it can provide a more rapid diagnostic confirmation by identifying 
suspicious cells, usually liver or amniotic cells (Fig. 26), (Spiegel et al., 2009). 
 
Fig. 25. Part of Gaucher cell 
showing typical fibrils.        
x 10,000 
Fig. 26. Niemann-Pick C: 
membranous whorls fill 
hepatocytes.   x 4,000 
Fig. 27. "Fructose holes" in 
hereditary fructose 
intolerance. x 6,000 
5.2 Cholestasis 
Cholestasis, appearing in conditions in which the bile flow is blocked, is still differentiated 
as extra-hepatic- and intra-hepatic. There are only few differential features revealed by 
electron microscopy. 
Pre-and post-natal bile-production and secretion may be hindered by morphological and 
functional abnormalities. Neonatologists are more troubled by jaundice associated to direct-
binding (conjugated) bilirubin frequently indicating the possibility of structural abnormalities, 
such as biliary atresia. Liver biopsy is usually required to confirm this life-saving surgical 
correction. Other conditions associated with conjugated bilirubin are listed in Table 1 and 
several reviews (Balistreri, 2002); Suchy, 2004). Meanwhile, new clinical, morphological and 
genetic characteristics continue to emerge (Bull et al., 1997; Bezerra & Balistreri, 1999; Davit-
Spraul et al., 2009). Other conditions, in which basic conditions are associated with 
cholestasis, are listed for differential diagnosis (Roberts, 2004 a). 
5.2.1 Ultrastructural features of cholestasis 
Hepatocytic mitochondria show circular, concentric or curled cristae (Fig. 10, 28). With 
continuing cholestasis, bile-containing bodies are seen as clusters, mostly around bile 
canaliculi. In their outer limit, a membranous structure is occasionally identified. The bile-
containing bodies, considered lysosomes, are electron-opaque organelles, usually 0.5-2.0 
(0.1-10.0) µm diameter (Fig. 29). Bile canaliculi display distension and damaged microvilli 
(Fig. 30). In time, spicular conglomerates become visible (Fig. 31). Myelin-like membranes 
are noticeable in long-standing cholestasis (Fig. 32). 
Bile leakage into the cytosol (amorphous, without limit membrane) appears after prolonged, 
severe cholestasis. Cells other than hepatocytes (Kupffer cells, sinusoidal lining cells, stellate 
cells, bile duct epithelia) exhibit variable degrees of cholestasis, mainly as bile-containing 
lysosomes. Focal biliary cytoplasmic necrosis is the extreme form of bile-induced hepatocytic 
damage, other than biliary cirrhosis (Fig. 33). 
www.intechopen.com




Fig. 28. Hepatocyte. 
Circular and curled cristae 
in cholestasis. Peroxysomes 
(P). x 8,000 
Fig. 29. Bile-containing 
lysosomes in the 
pericanalicular area. Note 
dilated RER. x 4,000 
Fig. 30. Distension of 
canaliculus (BC) and loss of 
microvilli in cholestasis.     
x 4,000 
Fig. 31.  Severe cholestasis: 
spicular bile  x 10,000 
Fig 32. Myelin-like 
lysosomes in a degraded 
hepatocyte.   x 8,000 
Fig. 33. Focal biliary 
cytoplasmic necrosis,  
near bile canaliculi.  
x 4,000 
Fig. 34. Cholestatic 
jaundice. “Byler-like“ bile 
in PFIC-1. x 6,000 
Fig. 35. PFIC-1. “Byler-like“ 
bile. Distended canaliculus, 
injured microvilli.  
X 4,000 
Fig. 36. Bile plug 
in biliary atresia. x 4,000 
BC 
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5.2.2 PFIC-1, PFIC-2 and PFIC-3 
PFIC-1 (former Byler disease) is caused by a mutation in the ATP8B1 gene on chromosome 
18q21-22. Byler-like bile, seen in PFIC-1, is formed of coarse granular bile in distended 
canaliculi with damaged/absent microvilli (Figs. 34-35). In contrast, the bile in PFIC-2 is not 
granular but filamentous, important for differential diagnosis. Bile plugs are typically seen 
in severe obstructive cholangiopathies including biliary atresia (Fig. 36).   
PFIC-2 is caused by a mutation in the ABCB11 gene on chromosome 2q24 that encodes the 
bile salt export pump (BSEP). BSEP is the major canalicular bile acid pump, and thus the loss 
of BSEP function results in severe hepatocellular cholestasis. Both PFIC-1 and PFIC-2 are 
characterized by low gamma-glutamyl peptidase (GGT) levels. Although genetically 
distinct, PFIC1 and PFIC2 are both caused by the absence of a gene product required for 
canalicular export and bile formation. Clinically and histologically there are few differences 
between these conditions, which may both advance to cirrhosis. An important contribution 
of electron microscopy to the otherwise ample description of histopathological features of 
PFIC, is the finding of the coarsely granular “Byler bile” in dilated canaliculi that lack 
microvilli and are cuffed by a thick layer of microfilaments. “Byler bile”, is apparently 
related to the defect in canalicular bile acid transport with primary retention of hydrophobic 
bile salts. Weber suggested the microfilament collar was a feature of cholestasis in another 
ethnic group (Weber et al., 1981).  Bull and co-authors reported that “Byler bile” was found 
only in children who were homozygous for the microsatellite haplotype at 18q21-q22 (PFIC 
1)(Bull et al., 1997). It should be noted that Byler bile can be seen occasionally in cholestatic 
conditions other than PFIC 1 or PFIC 2, such as Familial Progressive benign cholestasis 
(Phillips et al., 1987).   
The absence of bile salts in the bile ducts in PFIC1 and PFIC2 and their presence in the bile 
ducts in PFIC3 accounts for the difference in biochemical tests. In PFIC3, as in most 
cholestatic diseases, exposure of duct cell membranes to bile salts results in solubilization of 
GGT, absorption of the enzyme into the circulation, and elevated serum GGT levels. In 
contrast, in PFIC1 and PFIC2 there are low levels of bile salts, the GGT is never solubilized, 
and the serum GGT is normal. Rather than defective bile acid export, patients with PFIC3 
have deficient hepatocellular phospholipid export. The lack of phospholipids produces 
destabilized micelles and promotes lithogenic bile with crystallized cholesterol which could 
produce small bile duct obstruction (Davit-Spraul et al., 2009). The histological and 
ultrastructural features are similar to other forms of PFIC, except for the absence of Byler 
bile. In PFIC-3 the bile is amorphous or filamentous. The patients become symptomatic at 
various ages, from 1 month to 20 years, and progression to cirrhosis can be rapid (first 
decade). 
Recently (Verhulst et al.), 2010), reported on the critical role of ATP8B1 (deficient in PFIC-1) 
in apical membrane organization, potentially relevant for development of cholestasis and 
extrahepatic manifestations associated with ATB8B1 deficiency (such as disorganized apical 
actin cytoskeleton and defective microvilli formation) 
5.2.3 Crigler-Najjar 
This syndrome is divided into two types: type I and type II, with the latter sometimes called 
Arias syndrome. These two types, along with Gilbert's syndrome, Dubin-Johnson syndrome, 
and Rotor syndrome, make up the five known hereditary defects in bilirubin metabolism.  Unlike 
Gilbert's syndrome, only a few hundred cases of Crigler-Najjar syndrome are known to exist 
(Kelly, 2004). 
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5.2.4 Dubin-Johnson syndrome 
Originally termed canalicular multiple organic anion transporter (cMOAT) defect, it is also 
known as multidrug resistance protein 2 (MRP2) and is a member of the ABC transporter 
superfamily. The gene that encodes the transporter is ABCC2 is found on chromosome 10. 
Rare cases of neonatal hepatitis have been reported; in older children, histology and TEM 
show typical melanin-containing pigment predominantly in the centrilobular area, around 
bile canaliculi (Fig. 37). 
5.2.5 Alagille syndrome (Arteriohepatic dysplasia) 
Described in 1975, the syndrome comprises infantile cholestasis, hepatic ductular 
hypoplasia, typical facies, peripheral pulmonic stenosis, vertebral anomalies and physical 
and mental retardation. The persistence of cholestasis is not associated to extra-hepatic 
obstruction but paucity of intralobular bile ducts is frequent.  Valencia-Mayoral et al.  
have found ultrastructural changes suggesting a block in the Golgi apparatus or in  
the pericanalicular cytoplasm (Valencia-Mayoral et al., 1984).  These TEM findings in 
Alagille syndrome appear to be distinctive when compared to other cholestatic 
syndromes. 
5.2.6 Alpha-1-antitrypsyn deficiency (A1AT) 
This disorder is a relatively common autosomal co-dominant condition causing chronic 
lung and liver disease. ┙1-antitrypsin is a protease inhibitor belonging to the serpin 
superfamily. It is generally known as serum trypsin inhibitor. A point-mutation induces 
aggregation-prone properties to a secretory protein so that the retained mutant protein  
is not secreted into blood or body fluids. Accumulation of the mutant A1AT in the RER  
of hepatocytes, typically seen with the TEM (Fig. 38) causes liver inflammation  
and carcinogenesis by a gain-of-toxic function mechanism. Studies performed over the 
last years have shown the importance of autophagy in disposal of mutant, a phenomenon 
also demonstrated by TEM. In infancy, A1AT is an important cause of cholestatic 
jaundice, with giant cell hepatitis, mimicking biliary atresia and Alagille syndrome 
(Mowat, 1994). 
 
Fig. 37. Dubin-Johnson 
syndrome. Electron-dense 
accumulations adjacent to 
bile canaliculus. x 5,000 
Fig. 38. Alpha-1-antitrypsin 
deficiency: amorphous 
accumulations in RER. 
x 6,000 
Fig. 39. Congenital disorder 
of glycosylation (CDG). 
Pericanalicular clusters of 
single-membrane-bound 
bodies.  x 5,000
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5.3 Congenital disorders of glycosylation (CDG) 
This new group of genetic diseases characterized by defective glycoprotein biosynthesis 
exemplifies the value of electron microscopic diagnosis by liver biopsy (Iancu et al., 2007)  
The patients can present either with a neurological form (psychomotor retardation, 
cerebellar hypoplasia and retinitis pigmentosa, or with a multivisceral form with 
neurological and extra-neurological manifestation including liver, cardiac, renal or 
gastrointestinal involvement).  A form with liver involvement and/or cardiomyopathy, 
enteropathy and hypoglycemia has also been reported. Elevated transaminases may focus 
attention to the liver.  The biopsy shows increased cellularity, distorted bile ducts and small- 
and medium size lipid droplet steatosis.  TEM shows, in addition, the presence of numerous 
myelinosomes.  These organelles are mainly empty whorls measuring 0.02-0.1 µm and 
forming conglomerates (“grape-like“) close to bile canaliculi (Fig. 39). Isoelectric focusing of 
transferrin provides an easy method of identification of CDG’s. 
5.4 Galactosemia, fructose intolerance, tyrosinemia 
These inherited metabolic disorders are included here because of their common presentation 
with jaundice and elevated transaminases, as evidence of liver involvement. Although TEM 
results are not always specific, if a biopsy is performed, the findings can be supportive for 
life-saving diagnosis (Phillips et al., 1987; Mowat, 1994). 
Galactosemia: enlarged hepatocytes, dilated RER, fatty liver, focal cytoplasmic degeneration, 
biliary necrosis; 
Hereditary fructose intolerance: punched-out cytoplasmic lysis - “fructose holes” (Fig. 27).   
Tyrosinemia: Increased lipid, dilated RER, pleomorphic mitochondria and focal necrosis. 
5.5 Siderosis 
Inorganic iron is revealed by TEM in unstained or slightly stained sections. The  compounds 
are electron-dense due to the presence of ferritin and/or hemosiderin (Iancu, 1983; Iancu, 
1992) and (rarely) iron-containing micelles (Fig. 40), (Bessis & Weed, 1973; Iancu, 1983; Iancu, 
1992). The octahedral storage molecule ferritin (Holoferritin = ferritin core (Fe 
hydroxyphosphate) + apoferritin protein coat) becomes visible by TEM when the core 
contains more than about 1,500 inorganic iron molecules, up to a maximum of 4,500 
molecules (iron-rich ferritin). Ferritin molecules (cores) can be seen randomly dispersed 
within the cell sap of hepatocytes, sinusoidal and Kupffer cells (Fig. 41, 42) in amounts 
depending on the origin of overload (absorptional or transfusional). The accumulation of 
iron is easier detectable in lysosomes. Iron-containing lysosomes are termed siderosomes. They 
contain electron-dense iron in 3 forms: a) ferritin molecules (mostly iron-rich variety), 
frequently associated with pseudo-membranous layers and forming arrays or hexagonal 
crystals; b) coalesced ferritin particles (after degradation of their apoferritin coat) forming 
‘clumps’ of hemosiderin with extreme electron-density; c) siderosomes in which smaller 
particles can be resolved, apparently an intermediate stage between a) and b). Yet, a strict 
electron-microscopic definition of these compounds emphasizes that hemosiderin is formed 
when the coat of apoferritin is smaller than 0.25 nm and thus the distance between two 
ferritin molecules is reduced to less than 0.5 nm (Fischbach et al., 1971) 
The TEM study of liver siderosis reveals: presence of ferritin and/or hemosiderin within 
various cells; relationship with additional conditions (e.g. cirrhosis, hepatitis, and carcinoma); 
quantification of the iron-containing compound by mass spectrometry or other analytical 
methods; and assessment of putative effect of a chelating agent. TEM confirmed that iron 
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overload from excessive absorption (hemochromatosis HFE) produces parenchymal overload 
with an initial mild reticuloendothelial (RES) overload, while transfusional iron is located 
mostly in the RES, followed by re-distribution of excess iron among both compartments. 
5.5.1 Genetic hemochromatosis (HFE) “classical” hemochromatosis, type 1 
Hemochromatosis HFE is most often caused by a mutation in the gene HFE on chromosome  
6p21.3. Four types were identified (Muir et al., 1984), with differences between the degrees 
of liver iron loading. Children as young as 4 years had juvenile forms. The various stages of 
overload were followed by TEM (Iancu et al., 1997). 
5.5.2 Other iron-loading conditions 
In homozygous ┚-thalassemia, excess iron originates from hemolysis, increased absorption 
and frequent blood transfusions.  In the liver, “foreign “transfused iron is channeled to the 
(RES), whereas iron from excessive absorption reaches parenchymal cells. The end-result is 
severe overload possibly followed by cirrhosis and/or hepatocellular carcinoma. In aplastic 
anemia and dialysis, iron derives from transfusions, with predominant initial RES overload, 
followed by redistribution towards hepatocytes and aggravation of liver siderosis as seen at 
the ultrastructural level. (Iancu, 1989; Iancu, 2011). 
 
 
Fig. 40. Homozygous beta-thalassemia: 
Electron-dense iron micelles within 
mitochondria. x 20,000, unstained 
Fig. 41. Genetic hemochromatosis HFE. 
Ferritin cores in a Kupffer cell, dispersed 
and/or aggregated. x 20,000, unstained 
 
Fig. 42. Hepatocyte from ┚-thalassemia 
major. Ferritin dispersed or coalesced in 
crystals (curved arrow). In hemosiderin, 
(arrows) ferritin particles cannot be 
resolved anymore.  x 20,000, unstained
Fig. 43. Neonatal hemochromatosis, similar 
to genetic hemochromatosis: note ferritin 
of variable electron-density ("iron-rich” vs. 
“iron-poor”) and hemosiderin "clumps" 
(arrows). x 20,000, unstained.
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5.5.3 Neonatal hemochromatosis (NH) 
In the neonatal period, the liver normally contains relatively large amounts of ferritin and 
hemosiderin, which diminish during the first year of life. 
Neonatal hemochromatosis is a severe, frequently fatal condition.  It has been found in 
fetuses and newly born infants presenting with rapidly progressing liver failure. The 
pattern of liver siderosis is similar to that of hereditary hemochromatosis (HFE) but the 
pace of pathological changes is fulminant: there is a striking difference between the iron-
loaded hepatocytes and the sinusoidal cells which show only minor iron deposition. Perls’ 
stain reveals siderosis in extra-hepatic locations (pancreas, thyroid, heart). Until recently, 
the cause and mechanism of this condition were unknown.  Presently, NH is considered 
an alloimmune disease in which maternal antibodies damage the hepatocytes, especially 
post-partum. The siderosis is seen as secondary to the damaged liver cells and not the 
primary metabolic abnormality (Knisely & Vergani, ; Whitington, 2007). Because of the 
life-endangering condition of these infants, liver biopsy is rarely performed.  TEM reveals 
iron mainly in hepatocytes, stored similarly to other parenchymal loading disorders  
(Fig. 43). 
The role of iron in the brain and in Parkinson and Alzheimer diseases is under continuous 
study. Iron-induced lipid peroxidation and the formation of toxic free radicals appear to 
contribute to the development of the latter conditions (Zhu et al., 2007). Ongoing 
experimental work is focused on the effect of new chelating agents, capable to pass the 
blood-brain-barrier (Gal et al., 2006) and reduce the damaging effects of iron. Using cultured 
hepatoma-derived Hep3B cells loaded with inorganic iron, we could demonstrate the effect 
of a new bimodal chelator M30 capable of reducing ferritin in these cells, as seen by 
immunofluorescence (personal communications, Y Bashenko, 2009-2011). 
5.5.4 Wilson disease (WD) 
In this copper metabolism abnormality, there are numerous ultrastructural changes in liver 
cells as the liver lesions change in time, from chronic hepatitis to acute liver failure or 
cirrhosis. Alterations involve nuclei, mitochondria, peroxisomes, RER, fatty changes with 
lipolysosomes and neocholangioles with copper deposits (Figs.  44-47) (Sternlieb, 1979) 
Phillips et al., 1987). 
 
Fig. 44. Punched-out mitochondria and fat 
droplets in WD. x 6,000 
Fig. 45. Giant mitochondrion with 
punched-out areas and fat droplets.  
x 10,000 
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Fig. 46. WD: Mitochondria with crystalline 
deposits   and dense deposits (arrow) 
x 8,000 
Fig. 47.  Glycogen body (RER) frequently 
seen in WD. x 6,000 
5.6 Reye syndrome 
Around 1970, TEM had a major diagnostic role showing changes considered typical for 
Reye syndrome: generalized steatosis, glycogen depletion, increased frequency of 
peroxisomes and "amoeboid", occasionally giant mitochondria; their matrix was described 
as "flocculent" and frequently contained crystalline inclusions and lacked dense matrical 
granules (Figs. 48-49).  Towards 1980, possibly following the reduced aspirin 
consumption, the frequency of Reye syndrome decreased dramatically. However, 
sporadic cases still occurred without a clear relationship to aspirin ingestion. The 
ultrastructural findings were similar to those described in Reye syndrome, and were 
therefore named “Reye-like” (Phillips et al., 1987). In the UK, over 10% of reported cases 
with an initial diagnosis of Reye's syndrome have later been revised to an Inborn Metabolic 
Disorder (IMD) which may mimic Reye's syndrome.  IMD includes defects in fat oxidation, 
amino acid metabolism, carbohydrate metabolism and disorders of ammonia 
detoxification.  The relationship with aspirin ingestion was not firmly established, as Reye 
syndrome appeared in areas where aspirin was never used (Australia) and continued to 
appear after aspirin was discontinued (France). 
 
 
Fig. 48. Reye syndrome. Cristolysis and 
generalized lipid deposition (L) x 20,000 
Fig. 49. Reye syndrome. Expanded 
mitochondria, cristolysis, lipofuscin and 








This group includes presently: 1. Alcoholic liver disease; 2.  NAFLD (non-alcoholic fatty liver 
disease) which encompasses most forms of fatty liver, including “simple steatosis“, without 
inflammation, seen in an important percent of adult population (Fig. 50), and 3. NASH, (non-
alcoholic steatohepatitis) which by definition involves inflammation and/or fibrosis (Roberts, 
2004 b) and may progress to cirrhosis more frequently than simple steatosis. 
 
Fig. 50. Fatty liver - 
NAFLD:  Large droplets 
present in hepatocytes and 
sinusoidal cells   x 4,000 
Fig. 51. Total parenteral 
nutrition. Lipid droplets (L) 
strangle a minute bile 
canaliculus (arrow). x 6,000 
Fig. 52. Total parenteral 
nutrition. Spicular 
cholesterol within dense 
bodies. Abnormal 
mitochondria. x 8,000 
 
Fig. 53. NAFLD. 
Lipofuscin- lipolysosomes 
(arrows) near the sinusoid 
(S) and bile canaliculus 
(BC).  x 4,000 
Fig. 54. Hepatocyte. Typical 
lipolysosomes, Wilson 
disease. x 6,000 
Fig. 55. Compound 
lipolysosome.  
Note extreme size 
compared to adjacent 
nuclei; x 6,000  
For electron-microscopic characterization of liver steatosis, the classical terms “large 
droplet“(macrovesicular) and “small droplet“(microvesicular) are still used. Macrovesicular 
steatosis is mostly seen in nutritional abnormalities including: kwashiorkor, obesity, 
prolonged parenteral nutrition (Figs. 51-52), diabetes mellitus, glycogenoses, Wilson disease, 
hyperlipidemias, A-(or hypo) betalipoproteinemia, familial lipoprotein deficiency, total 
lipodystrophy (Sherlock & Doodley, 1993). Microvesicular steatosis is frequently found in 
mitochondrial dysfunctions, urea cycle enzyme defects, lysosomal storage diseases, Reye- 
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Fat droplets of various sizes can be seen mostly, but not only, in hepatocytes. The ubiquitous 
triglyceride droplets have a round contour, are only slightly electron dense and usually have no 
surrounding limit membrane. Even in cells apparently completely filled-up with fat droplets, the 
changes in other organelles are rare, with the exception of crystal formation in mitochondria, 
seen more frequently.  Occasionally, a fat droplet can be seen in the nucleus as well.   
5.7.1 Atypical lipid-containing organelles 
Membrane-bound lipid droplets (lipolysosomes) are frequently seen in hepatocytes in 
association with triglyceride-containing droplets. 
We distinguish between several types of lipid-containing, membrane-bound bodies: 
1. Lipolysosomes as described by Hayashi and Sternlieb, and Kanai et al.(Hayashi & 
Sternlieb, 1975; Hayashi et al., 1983; Kanai et al., 1994). Electron-lucent droplets, usually 
up to 10 µm in diameter, with uniform content and surrounded by a trilaminar 
membrane. Of special interest are vesicles (attachments) to the outer leaflet of the 
surrounding membrane and associated lipofuscin (Figs. 53). 
2. Multivesicular bodies, described by Phillips et al. (1987) as lipolysosomes, containing 
numerous smaller droplets with lipidic aspect (Fig. 54).  Such lipolysosomes have been 
observed frequently in Wilson disease and in patients with NAFLD. They are 
frequently seen in hepatocytes showing increased amounts of typical lipofuscin 
3. Giant lipolysosomes (Fig. 55) which we suggest to name “compound lipolysosomes“, 
observed in  cases of extreme overweight (Haimi et al., 2011).  They appear to be formed 
by the fusion of numerous lipolysosomes of usual size, through a process similar to the 
formation of “compound siderosomes“ describe in iron overload (Roy & Ghadially, 1967). 
6. Infections and infestations (See Table 1) 
Negative staining is required for identification of some viral particles while others display 
characteristic features in cytosol or nucleus in various liver cells. In acute hepatitis, remnants 
of apoptotic hepatocytes form eosinophilic acidophilic bodies (Fig. 56). They are then expelled 
from the cell aggregate and later phagocytized by macrophages. Other cells undergo 
necrosis without an identifiable apoptotic stage (Fig. 57). 
  
 
Fig. 56. Acidophilic body (arrow) in           
the sinusoid.  Fat droplets, disintegrated 
nucleus and phagolysosomes are still 
recognizable.  x 5,000 
Fig. 57. Acute hepatitis: Membranous 
phagolysosomes in a necrotic hepatocyte.     
x 6,000 
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Fig. 58. Acute hepatitis.  Mononuclear cells 
in sinusoid. x 4,000 
Fig. 59. Echinoccocus granulosum: hooklets 
(arrows) in the liver biopsy retrieved at 
surgery. x 10,000 
The presence of inflammatory reactions, mostly of viral origin, is visualized by TEM initially 
by the presence of mononuclear cells in sinusoids (Fig. 58).  Focal cytoplasmic degeneration 
precedes changes recognizable by light microscopy, to be followed by apoptosis and 
eventually necrosis. The identification of various hepatitis etiological agents is beyond the 
routine liver biopsy examination. The occasional encounter with parasites (Fig. 59) has an 
investigational character, 
7. Drug hepatotoxicity 
With the exponential increase in the number of drugs (medication) there is a parallel increase 
in the number of side- and toxic effects reported by patients. Many of these are related to liver 
function and metabolism and to the major de-toxifying role of this organ. In drug-induced 
damage, autophagosomes are frequently seen (Fig. 60) occasionally containing mitochondria 
(Fig. 61). In this review we will exemplify only a few of these toxic changes as seen by electron 
microscopy: non-specific effects, from mild and reversible to severe and life-endangering are 
listed in Table 1. In addition, there are some specific features which enable diagnosis of the 
offending compound: amiodarone, NSAIDs, aspirin, corticosteroids. 
 
 
Fig. 60. Drug toxicity.  
Autophagosomes (arrows) 
contain fat and multiple 
membranes.  x 15,000 
Fig. 61. Valproate toxicity. 
Mitochondria secluded in 
autophagolysosome.            
x 15,000 
Fig. 62. Corticosteroid 
effect. Lipid and excessive 
glycogen in a bi-nucleated 
hepatocyte.  x 6,000 
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Mitochondrial matrix with dense deposits 
‘Ballooned’ mitochondria, ‘Extraction’ of 
nuclei 
Myelin-like whorls in mitochondria 
Infections/ infestations
Hepatitis, herpes-varicella group 
virus 
viral particles 
Hepatitis, acute (HBV) 
viral particles (HBsAg)
Nuclear Dane particles (HBcAg) 
Infectious mononucleosis Ebstein-Barr virus
Cytomegalovirus infection 
Electron-dense particles in hepatocytes (no 
virus) 
Kala-Azar Leishmania bodies in Kupffer cells 
Malaria Schizonts in Kupffer cells




Inherited disorders (Constitutional, 
non-hemolytic)
 
Crigler-Najjar syndromes, type 1 & 2 
Intracanalicular bile thrombi, increased 
intercellular space.
Gilbert’s disease 
Flattening of hepatocyte microvilli, reduced 
RER, proliferated SER.
Conjugated hyperbilirubinemia
Cholangiopathies - Cholestasis (most 
etiologies) 
Curled cristae in mitochondria; dense 
deposits in cell sap; amorphous and/or 
filamentous bile cytolysosomes mostly 
around bile canaliculi; focal biliary necrosis; 
dilated & distorted bile canaliculi with 
abnormal microvilli and bile plugs. 
Pericanalicular cytoplasm may show 
microfilaments. 
Biliary atresia - Biliary duct 
obstruction 
Extensive cytoplasmic cholestasis, 
cytoplasmic biliary necrosis; pericanalicular 
filamentous cuff. 
Cystic fibrosis 
Cholestasis in infancy; aggregates of 
osmiophilic material in lumen; collagen; 
steatosis; ductule dilatation; many stellate 
cells.
Alagille 
Numerous bile-containing cytolysosomes and 
vesicles in Golgi; canaliculi can be empty. 
 
PFIC 1 (ATP8B1) 
Severe cholestasis (hepatocytes, sinusoidal 
cells, bile ducts, granular Byler bile). 
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PFIC 2 (ABCB11) 
As in PFIC-1 but amorphous and filamentous 
bile in canaliculi. 
PFIC 3 (ABCB4) 
As in PFIC 1 & PFIC 2 but amorphous and 
filamentous bile in canaliculi. 
Dubin-Johnson syndrome 
Lipofuscin-like pigment, abnormal bile 
canaliculi. 
Rotor syndrome 
Megamitochondria, reduced microvilli in bile 
canaliculi. 
  
Carbohydrate metabolism  
Glycogen Storage Diseases (GSD) 
Type I,(I-a) III, VI, VIII, IX, X, XI 
Accumulation of cytosolic glycogen in 
hepatocytes; displacement of organelles; 
frayed ┙-glycogen in types VI, VIII, IX, X. 
Type IIa, b, c 
Abnormal glycogen-containing lysosomes: 
glycogenosomes. 
Type IV (amilopectinosis) 
Abnormal structural glycogen, collagen 
deposition and cirrhosis. 
Diabetes mellitus 
As for GSD I and III; micro- and 
macrovesicular steatosis. 
Hyperglycogenation of nuclei. 
Lipolysosomes, lipofuscin; mitochondrial 
crystalline inclusions. 
Hereditary fructose intolerance 
Concentric membranous arrays in 
hepatocytes; Areas of cytoplasmic damage: 
‘Fructose holes’: abundant glycogen, 
prominent lipid droplets, large autophagic 
glycogen-containing vacuoles, myelin 
figures, focal cytoplasmic degradation. 
Galactosemia 
Hepatocytes: rosette or pseudoglandular 
formation; multinuclear hepatocytes. 
Cholestasis; large lipid droplets; distended 
RER 
 
Disorders of glycoprotein 
metabolism 
 
Mucopolysaccharidoses : Hurler, 
Hunter, Sanfilippo, Scheie, Morquio, 
Maroteaux-Lamy 
Abnormal lysosomes in hepatocytes, RER, 
sinusoidal cells and vascular epithelia; 




Lysosomes with variable membranous 
content. 
Sialidosis (Mucolipidosis I) 
Fine reticular-granular content of lysosomes 
(hepatocytes and sinusoidal cells). 
Mannosidosis 
Fine reticular-granular content of lysosomes. 
Electron-opaque globules in Kupffer cells. 
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“Empty lysosomes “: parenchymal & 
sinusoidal cells. 
Glutamyl ribose 5-phosphate 
glycoproteinosis 




Mucolipidosis II (I-cell disease) 
Cytoplasmic membrane- bound vacuoles 
containing fibrillose-granular material. 
Mucolipidosis III (Pseudo-Hurler) Vacuoles in cultured fibroblasts.
Mucolipidosis IV 
Hepatocytes: lamellar inclusions; Kupffer 
cells: fibrogranular material in lysosomes. 
Alpha-1-AT deficiency Amorphous accumulations in hepatocytic RER. 
  
Disorders of lipid metabolism  
Sphingolipidoses - Gangliosidoses  
GM1 (generalized gangliosidosis) 
Landing) 
Membranous cytoplasmic bodies. Lipid-
laden histiocytes (liver).
GM2 (Tay-Sachs, Sandhoff disease) Membranous cytoplasmic bodies.
Glycosphingolipid lipidosis (Fabry 
disease) 
Lysosomal concentric arrays disease. 
Lactosyl ceramidosis Lysosomal lamellae.
Sulphatidosis (metachromatic 
leukodystrophy) 
Hepatocytic lamellar inclusions “Herring 
bone” 
Glucocerebrosidosis (Gaucher disease) Gaucher cells.
Ceramidosis (Farber disease) 
Hepatocytic vacuoles and dense bodies; 





Lysosomal concentric membranes in 
hepatocytes and sinusoidal cells. 
Abetalipoproteinemia 
Macrovesicular liver steatosis.
Deficient trans-Golgi vacuole formation 
Familial lipoprotein deficiency Lipolysosomes in foam cells of RES. 
Acid lipase deficiency & Wolman 
disease 
Foamy histiocytes containing acicular crystal 
lipid droplets in hepatocytes and histiocytes. 
Cholesteryl ester storage disease Cholesteryl ester crystals in Kupffer cells. 
Ceroid lipofuscinosis 
Lipofuscin and tubular structures in 
lysosomes. 
Chanarin-Dorfman disease Ichthyosis, fatty liver, cirrhosis.
Steroid therapy, prolonged Macrovesicular liver steatosis.
Total lipodystrophy &
Parenteral nutrition
Macrovesicular steatosis, lipid lakes, 
cholestasis
 
Disorders of protein metabolism
Tyrosinemia 
Cholestasis, steatosis, abnormal MV, collagen 
in space of Disse.
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Large lysosomes in hepatocytes &Kupffer cells. 
Membranous structures in mitochondria. 
Carbamyl phosphate synthetase 
deficiency 
Concentric RER, small mitochondria with 
high matrix density. 
Lysinuric protein intolerance with 
deficient transport of basic amino acids 
Increased SER; large vesicles filled with 
fibrogranular material. 
Carnitine palmoyl transferase 
deficiency 
Large-droplet fatty liver. 
Hyperornithinemia 
Megamitochondria, abnormal shapes and 
membranes. 
Cystinosis Crystals in Kupffer cell lysosomes. 
Homocystinuria 
Mitochondria abnormal shapes, SER. 




Primary and secondary 
hemochromatosis 
Ferritin in cytosol and lysosomes 
(siderosomes) Hemosiderin only in 
lysosomes (most cell lines) 
Transfusional siderosis 





Heavy parenchymal siderosis, less in RES 
(distribution similar to hemochromatosis) 
Brain and systemic siderosis, including liver 
Association with lipofuscin 
Ferritin and hemosiderin in compound 
lysosomes with lipofuscin. 
Copper 
Wilson disease 
Abnormal mitochondria, abnormal 
peroxisomes, lipolysosomes, fatty liver, 
electron-dense deposits. 
Menkes’ kinky hair syndrome Cartwheel-like cristae in mitochondria. 
  
Peroxisomal disorders
Zellweger syndrome Absent peroxisomes.
Hepatic acatalasia syndrome Absent peroxisomes.
Neonatal adrenoleukodystrophy Few, small, peroxisomes.
Primary hyperoxaluria Type I Few, small, peroxisomes
Infantile Refsum’s disease 
Few, small peroxisomes; angulated 
lysosomes. 
 
Drug Toxicity – general features 
Mitochondrial changes(absent dense matrical 
granules, paracrystalline formation); RER 
dilatation, SER proliferation; increased. 
frequency of lysosomes 
(autophagolysosomes); apoptosis, focal 
necrosis, lipofuscinosis. 
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Corticosteroid therapy, high dosage, 
short term 





Large droplet fatty liver, abnormal 
mitochondria. 
Chediak-Higashi disease 
Abnormal inclusions in Kupffer cells and 
hepatocytes. 
Erythrohepatic-protoporphyria 
Amorphous or needle-like pigment  
in hepatocytes and Kupffer  
cells.
Erythroblastosis fetalis 
Erythroblasts and reticulocytes in liver 
parenchyma. 





Mitochondrial changes, vesiculated SER, 
cholestasis, lipofuscin, in hepatocytes and 
Kupffer cells. 
Reye syndrome & Reye-like 
syndrome 
Microvesicular fatty liver, abnormal 
mitochondria, many peroxisomes. 
Table 1. Electron Microscopic findings in different conditions 
7.1 Corticosteroid effect 
Fatty liver has been reported among the side-effects of prolonged large-dose steroid therapy 
(Sherlock & Doodley, 1993). Three patients aged 8, 10 and 12 year respectively, treated with 
medium-high doses of corticosteroids presented with hepatomegaly and elevated 
transaminases of unknown origin.  Liver biopsy performed to elucidate these findings, 
revealed (by TEM) excessive glycogen in hepatocytes, to the extent of justifying 
hepatomegaly. The increased amount of hepatocytic glycogen displaced mitochondria and 
other components towards the nucleus and plasma membrane (Fig. 62).  The pattern was 
similar to that of glycogen storage diseases observed in type III and IX. Lipid droplets were 
scarce. After the steroid therapy was discontinued, the liver size returned to normal (Iancu 
et al., 1986). 
7.2 Amiodarone 
Changes similar to alcoholic liver injury are commonly found. Steatosis, is the  
most frequent histopathological feature. Ballooning of hepatocytes, Mallory bodies, and 
fibrosis are common. Other changes include nuclear unrest, acidophilic bodies, foam  
cells, hyperglycogenated nuclei, and portal inflammation. Characteristic lamellar 
lysosomal inclusion bodies representing phospholipidosis should be better designed  
as “myelinosomes“(Fig. 63), (Ghadially, 1997). The cytotoxic pseudoalcoholic changes 
could be an independent phenomenon in susceptible patients unable to metabolize the 
drug.  The true incidence of hepatic injury from amiodarone remains to be determined 
from prospective evaluations of pretreatment and follow-up liver biopsies (Lewis et al., 
1990). 
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Fig. 63. Amiodarone 
toxicity: lamellar phosphor-
lipidosis in a lysosome         
x 10,000 
Fig. 64. Aspirin toxicity: 
dilated RER; steatosis, 
shrunken nuclei.  x 4,000 
Fig. 65. Aspirin toxicity: 
dilatation of RER; 
crystalline deposits.  
x 10,000 
7.3 Acetylsalicylic acid (Aspirin) 
In addition to its suspected relationship to Reye syndrome, aspirin, in large doses, has been 
found to increase the level of transaminases, a reversible reaction. TEM of a liver biopsy of a 
patient disclosed hepatotoxicity: dilatation of RER, mitochondrial changes 
(megamitochondria, crystalline formation), nuclear changes and lipofuscinosis (Figs. 64-65), 
(Iancu & Elian, 1976). 
7.4 Acetaminophen (Paracetamol) 
Frequently used as a suicidal drug, paracetamol can precipitate fatal liver failure when 
dosage is beyond 8–10g. TEM of experimental animals and cultured hepatoma-derived 
cells (HepG2 and Hep3B) disclosed the different stages of dose-related toxicity. Of note, 
the anti-oxidant N-acetylcysteine did not protect cultured cells against acetaminophen-
induced apoptosis (Manov et al., 2002; Manov et al., 2004). Various aspects of 
ultrastructural damage induced by non-steroidal anti-inflammatory drugs (NSAIDs) are 
described in detail in a review of hepatotoxicity of anti-inflammatory and analgesic drugs 
(Manov et al., 2006). 
8. Conclusions 
Transmission electron microscopy of liver biopsies provides: 
1. Typical diagnostic findings for a relatively small, but important, number of 
pathological conditions. 
2. Supportive information for a larger group of suspected conditions which require 
further confirmation. 
3. Important exclusion of conditions which were considered in differential diagnosis. 
Furthermore, it remains an essential research tool in all areas of bio-pathology. 
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